Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center

Aging Clin Exp Res. 2021 Feb;33(2):443-450. doi: 10.1007/s40520-020-01784-w. Epub 2021 Jan 28.

Abstract

Background: The best policy to follow when nursing homes are massively hit by SARS-CoV2 is unclear.

Aim: To describe COVID-19 containment in a nursing home transformed into a caring center.

Methods: Physicians and nurses were recruited. The facility was reorganized and connected with the laboratory of the reference hospital. Ultrasound was used to diagnose pneumonia. Patients needing intensive care were transferred to the reference hospital. Hydroxychloroquine/azithromycin/enoxaparin were used initially, while amiodarone/enoxaparin were used at a later phase. Under both regimens, methylprednisolone was added for severe cases. Prophylaxis was done with hydroxychloroquine initially and then with amiodarone.

Period covered: March 22-July 31, 2020.

Results: The facility was reorganized in two days. Ninety-two guests of the 121 (76%) and 25 personnel of 118 (21.1%) became swab test positive. Seven swab test negative patients who developed symptoms were considered to have COVID-19. Twenty-seven patients died, 23 swab test positive, 5 of whom after full recovery. Four patients needing intensive care were transferred (3 died). Mortality, peaking in April 2020, was correlated with symptoms, comorbidities, dyspnea, fatigue, stupor/coma, high neutrophil to lymphocyte ratio, C-reactive protein, interleukin-6, pro-calcitonin, and high oxygen need (p ≤ 0.001 for all). Among swab-positive staff, 3 had pneumonia and recovered. Although no comparison could be made between different treatment and prophylaxis strategies, potentially useful suggestions emerged. Mortality compared well with that of nursing homes of the same area not transformed into care centers.

Conclusion: Nursing homes massively hit by SARS-CoV-2 can become caring centers for patients not needing intensive care.

Keywords: Amiodarone; Elderly patients; Nursing home; SARS-CoV-2 infection.

MeSH terms

  • COVID-19*
  • Humans
  • Hydroxychloroquine
  • Nursing Homes
  • RNA, Viral
  • SARS-CoV-2*

Substances

  • RNA, Viral
  • Hydroxychloroquine